FINWIRES · TerminalLIVE
FINWIRES

EMEA Oil Update: Futures Ease From Record Highs as Middle East Conflict Intensifies

作者

-- Oil futures eased on Thursday with Brent breaching $126 per barrel mark earlier in the session as traders braced for a prolonged supply deficit fueled by the US-Iran war.

Front-month Murban crude futures slipped by 3.4% to $109.61 per barrel, while Brent futures fell 3.3% to $114.11/bbl and hit a high of $126 earlier in the session.

"Brent cracks 120/bbl as supply shortages mount," ANZ analysts said.

"The rally in crude oil prices shows no signs of slowing, as the prospect of an indefinite closure of the Strait of Hormuz weighs on sentiment," ANZ added.

The breakdown in diplomacy, paired with a directive from President Trump to prepare for an extended blockade, has left traders bracing for a protracted supply deficit that demand destruction alone may not be able to bridge.

"The breakdown of talks between the US and Iran, along with President Trump reportedly rejecting Iran's proposal for a reopening of the Strait of Hormuz, has the market losing hope for any quick resumption in oil flows," ING said.

"While we estimate demand destruction in the region of 1.6m b/d, which is significant, it's clearly not enough to fill the supply gap we are currently facing," ING added.

The market's ability to rely on existing stockpiles is rapidly eroding.

Data from analytics firm Kpler indicates that Iran has only 12 to 22 days of unused storage capacity remaining.

Once these facilities are full, Tehran will be forced to cut daily output by an additional 1.5 million to 1.6 million barrels per day.

This looming cut would be layered on top of the estimated 10 mb/d already shut in due to the strait's closure.

ING analysts warned that while regional demand destruction is estimated at roughly 1.6 mb/d, it remains insufficient to fill the widening supply gap, suggesting that significantly higher prices may be the only remaining lever to balance the market.

US crude stockpiles dropped by 6.2 million barrels to 459.5 mmbbls in the week ended April 24, the Energy Information Administration said in its weekly report on Wednesday, amid signs of tightening supplies.

Meanwhile, Trump on Wednesday reportedly said the UAE's decision to leave OPEC could help ease rising energy prices.

相關文章

Sectors

產業動態:消費者

週四下午,消費性股票走高,道富消費必需品精選行業SPDR ETF (XLP)上漲1.4%,道富非必需消費品精選行業SPDR ETF (XLY)上漲0.4%。 公司方面,蘭姆韋斯頓(LW)股價上漲1.6%,此前股東Starboard Value週四致信董事會,表示公司應召開投資者日活動,並將盈利預期調整至正常水平。

$LW
Research

研究快訊:CFRA維持對Firstenergy Corp.股票的買進評等。

獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下:我們將12個月目標股價下調1美元至55美元,本益比為20倍,基於未來12個月每股收益預期2.75美元,高於五年平均15.6倍。我們將2026年每股收益預期下修0.02美元至2.72美元,並將2027年每股收益預期下修0.01美元至2.93美元。第一季核心每股收益年增7.5%,打破了先前連續三個季度下滑的局面,我們預計在整個預測期內,成長動能將持續。 我們觀察到資料中心需求呈現正面趨勢,長期合約需求(4.3 GW)自 2026 年 2 月(4.1 GW)以來成長了 4%,自 2025 年 2 月(2.9 GW)以來成長了 47%;同時,在建專案需求(14.9 GW)自 2026 年 2012 年 125%, 2 月(6.1 GW)以來增長了一倍以上。自 2022 年以來,FE 已將基礎維運成本降低了 2 億美元以上(15%),預計 2026 年第一季將年比進一步下降約 5%,同時可靠性指標也得到提升。我們認為,FE 的成本控制、服務品質的提升以及具有競爭力的價格定位,將轉化為更有利的費率調整結果、更低的拒付風險以及更高的潛在淨資產收益率 (ROE)。

$FE
Australia

市場動態:FDA專家小組投票反對阿斯特捷利康乳癌藥物的益處

根據彭博社週四報道,美國食品藥物管理局(FDA)腫瘤藥物諮詢委員會否決了阿斯特捷利康(AZN)用於治療乳癌的候選藥物卡美司群(Camizestrant)的療效。 彭博社稱,六名委員會成員投票反對該藥物,因為他們對試驗設計及其在臨床應用中的潛在影響存在分歧。 根據一份簡報文件,該藥物試驗達到了無惡化存活期(PFS)的主要終點以及無惡化存活期2(PFS2)終點,但FDA認為PFS2不適合作為監管決策的終點。 (市場動態新聞來自與全球市場專業人士的對話。這些資訊據信來自可靠來源,但可能包含傳聞和推測。準確性無法保證。)Price: $189.60, Change: $+4.40, Percent Change: +2.37%

$AZN